Spots Global Cancer Trial Database for ly3022855
Every month we try and update this database with for ly3022855 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of LY3022855 In Participants With Breast or Prostate Cancer | NCT02265536 | Neoplasms Neoplasm Metast... | LY3022855 | 18 Years - | Eli Lilly and Company | |
A Study of LY3022855 In Participants With Breast or Prostate Cancer | NCT02265536 | Neoplasms Neoplasm Metast... | LY3022855 | 18 Years - | Eli Lilly and Company | |
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors | NCT02718911 | Solid Tumor | LY3022855 Durvalumab Tremelimumab | 18 Years - | Eli Lilly and Company |